EMILY BRODIN: Open Payments
NPI 1932898897 · NEWBERG, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 16 payments from 6 companies in 2025. Trend: 2023 $15 · 2024 $69 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $100 |
| ABBVIE INC. | 4 | $74 |
| Alkermes, Inc. | 2 | $64 |
| Lundbeck LLC | 3 | $53 |
| Novo Nordisk Inc | 3 | $48 |
| Lilly USA, LLC | 1 | $15 |
Products named: REXULTI, ARISTADA, VRAYLAR, Ozempic, QULIPTA, Wegovy, MOUNJARO.
Industry payments across OR — which companies pay providers there.
